// App-Quantinova.ai

2066 : Albumin-binding doxorubicin prodrug selectively activated by radiation-induced apoptotic tumor cells

Researchers

Presenter

  • Seung Woo Chung

Principal Investigators

  • Kwangmeyung Kim

  • Seong Who Kim

  • In-San Kim

  • Sang Yoon Kim

  • Youngro Byun

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Human albumin

Drug/Treatment

  • doxorubicin prodrug

  • S-DOX

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved